by Zachary | Dec 28, 2024 | Emerging Trends
Jayden Lee, EMBA, PharmD, BCACP & Husna Rahim, PharmD Pharmacogenomics and Drug Development: Accelerating the Process Towards Precision Medicine. Will pharmacogenomic testing accelerate the development of new medications? With the rise of costs and risks of drug...
by Zachary | Dec 28, 2024 | Emerging Trends
Zachary S. Brooks, PhD & Husna Rahim, PharmD Precision Oncology and Biomarker Tests: A New Era of Personalized Cancer Care. Is genomic medicine a viable option to advance cancer treatment in today’s data driven environment? By utilizing detailed biomarker...
by Zachary | Dec 28, 2024 | Emerging Trends
Jennifer Tovar, PharmD & Husna Rahim, PharmD Pharmacogenomics and Global Health Inequities: Bridging the Gap. How can pharmacogenomics (PGx) contribute to health equity on a global scale? Investing in PGx research in underrepresented populations can lead to...
by Zachary | Dec 28, 2024 | Emerging Trends
Jennifer Tovar, PharmD & Husna Rahim, PharmD Can pharmacogenomics (PGx) reshape the diagnosis and treatment of rare diseases? Rare diseases, as the name implies, affect a small portion of the population. PGx offers a new avenue for precision medicine in rare...
by Zachary | Dec 27, 2024 | Emerging Trends
Husna Rahim, PharmD & Jennifer Tovar PharmD Minimizing risks of Drug Reactions Pharmacogenomics. Your Reliable results. How does implementing pharmacogenomics in patient care reduce the incidence of adverse drug reactions? Pharmacogenomics (PGx) involves the study...
by Zachary | Dec 27, 2024 | Emerging Trends
Jayden Lee, EMBA, PharmD, BCACP & Zachary S. Brooks, PhD, EMBA What’s the first thing you think of when you hear the word “pharmacogenomics”? What is the purpose of most pharmacogenomic research? If you think about how your body processes the medications you take,...
